| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 4.90e-06 | 5 | 159 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 9.74e-06 | 6 | 159 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 4.02e-05 | 9 | 159 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 5.71e-05 | 10 | 159 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 1.34e-04 | 13 | 159 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 1.69e-04 | 14 | 159 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 2.57e-04 | 16 | 159 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 2.57e-04 | 16 | 159 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 3.10e-04 | 17 | 159 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 3.70e-04 | 18 | 159 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 5.11e-04 | 20 | 159 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 6.83e-04 | 22 | 159 | 3 | GO:0050998 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 4.50e-07 | 3 | 159 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 4.44e-06 | 5 | 159 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 8.84e-06 | 6 | 159 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 8.84e-06 | 6 | 159 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of mesoderm development | 2.45e-05 | 8 | 159 | 3 | GO:2000380 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 2.45e-05 | 8 | 159 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 3.65e-05 | 9 | 159 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 4.45e-05 | 26 | 159 | 4 | GO:0086064 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 6.95e-05 | 29 | 159 | 4 | GO:0031954 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 7.09e-05 | 11 | 159 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 7.97e-05 | 30 | 159 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 9.40e-05 | 12 | 159 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 9.40e-05 | 12 | 159 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.21e-04 | 13 | 159 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.48e-04 | 35 | 159 | 4 | GO:0010644 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | ATP6V1B2 CALM1 CALM2 CALM3 SH3GLB2 ARPC3 AP2A2 UNC13C BSN RIMS2 | 2.00e-04 | 321 | 159 | 10 | GO:0099003 |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 2.34e-04 | 16 | 159 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 2.82e-04 | 17 | 159 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 3.37e-04 | 18 | 159 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | positive regulation of TOR signaling | 3.43e-04 | 78 | 159 | 5 | GO:0032008 | |
| GeneOntologyBiologicalProcess | negative regulation of mesoderm development | 3.51e-04 | 4 | 159 | 2 | GO:2000381 | |
| GeneOntologyBiologicalProcess | positive regulation of TORC2 signaling | 3.51e-04 | 4 | 159 | 2 | GO:1904515 | |
| GeneOntologyCellularComponent | transport vesicle membrane | ATP6V1B2 CLTCL1 CALM1 CALM2 CALM3 AP1M2 DBH UNC13C BSN SEC23B | 1.05e-04 | 293 | 163 | 10 | GO:0030658 |
| GeneOntologyCellularComponent | calyx of Held | 1.73e-04 | 36 | 163 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | vesicle coat | 1.77e-04 | 67 | 163 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | transport vesicle | ATP6V1B2 CLTCL1 CALM1 COPB1 CALM2 CALM3 AP1M2 DBH AP2A2 UNC13C BSN HCK SEC23B | 2.24e-04 | 519 | 163 | 13 | GO:0030133 |
| GeneOntologyCellularComponent | neuron projection terminus | 4.99e-04 | 233 | 163 | 8 | GO:0044306 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 5.29e-04 | 129 | 163 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 7.35e-04 | 23 | 163 | 3 | GO:0098831 | |
| Domain | - | ZYG11A STK36 COPB1 NEK10 USP9X MROH5 XPO4 PSMD1 RIF1 AP2A2 PKP2 | 3.65e-06 | 222 | 161 | 11 | 1.25.10.10 |
| Domain | ARM-type_fold | ZYG11A STK36 CLTCL1 COPB1 NEK10 USP9X MROH5 XPO4 PSMD1 DOCK5 RIF1 AP2A2 PKP2 | 7.89e-06 | 339 | 161 | 13 | IPR016024 |
| Domain | ARM-like | ZYG11A STK36 COPB1 NEK10 USP9X MROH5 XPO4 PSMD1 RIF1 AP2A2 PKP2 | 2.31e-05 | 270 | 161 | 11 | IPR011989 |
| Domain | CAP | 2.65e-04 | 15 | 161 | 3 | PF00188 | |
| Domain | SCP | 2.65e-04 | 15 | 161 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 2.65e-04 | 15 | 161 | 3 | IPR001283 | |
| Domain | - | 2.65e-04 | 15 | 161 | 3 | 3.40.33.10 | |
| Domain | CAP_domain | 2.65e-04 | 15 | 161 | 3 | IPR014044 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.65e-08 | 5 | 122 | 4 | MM14493 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 7.90e-08 | 6 | 122 | 4 | MM15662 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.25e-07 | 15 | 122 | 5 | MM15103 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 1.83e-07 | 7 | 122 | 4 | MM1357 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 6.51e-07 | 9 | 122 | 4 | M3412 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.18e-05 | 35 | 122 | 5 | MM15109 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 1.24e-05 | 6 | 122 | 3 | MM14494 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.87e-05 | 19 | 122 | 4 | M47957 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 6.89e-05 | 26 | 122 | 4 | MM1346 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 6.89e-05 | 26 | 122 | 4 | MM14495 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 6.89e-05 | 26 | 122 | 4 | MM1431 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 7.26e-05 | 10 | 122 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 7.26e-05 | 10 | 122 | 3 | M47954 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 8.03e-05 | 27 | 122 | 4 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 8.03e-05 | 27 | 122 | 4 | M7739 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.03e-05 | 27 | 122 | 4 | MM15053 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 9.92e-05 | 11 | 122 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 9.92e-05 | 11 | 122 | 3 | M47958 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.07e-04 | 29 | 122 | 4 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 1.07e-04 | 29 | 122 | 4 | M13494 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.31e-04 | 57 | 122 | 5 | MM15643 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 1.31e-04 | 12 | 122 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.31e-04 | 12 | 122 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 1.31e-04 | 12 | 122 | 3 | M47956 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.59e-04 | 32 | 122 | 4 | MM1355 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.70e-04 | 13 | 122 | 3 | MM15078 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.80e-04 | 33 | 122 | 4 | M9494 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.15e-04 | 14 | 122 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.15e-04 | 14 | 122 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.15e-04 | 14 | 122 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.15e-04 | 14 | 122 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.15e-04 | 14 | 122 | 3 | MM15391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.67e-04 | 15 | 122 | 3 | M47385 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 2.67e-04 | 15 | 122 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 2.67e-04 | 15 | 122 | 3 | MM14795 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.67e-04 | 15 | 122 | 3 | M15181 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.26e-04 | 16 | 122 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 3.26e-04 | 16 | 122 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 3.26e-04 | 16 | 122 | 3 | M47449 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.47e-04 | 39 | 122 | 4 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 3.47e-04 | 39 | 122 | 4 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 3.47e-04 | 39 | 122 | 4 | M1908 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.64e-04 | 109 | 122 | 6 | MM15074 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 3.69e-04 | 71 | 122 | 5 | MM15590 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 3.84e-04 | 40 | 122 | 4 | M39595 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 3.94e-04 | 17 | 122 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 3.94e-04 | 17 | 122 | 3 | M47387 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 3.94e-04 | 17 | 122 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 3.94e-04 | 17 | 122 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 3.94e-04 | 17 | 122 | 3 | M2349 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 3.94e-04 | 17 | 122 | 3 | M47560 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 4.64e-04 | 42 | 122 | 4 | MM1504 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 4.69e-04 | 18 | 122 | 3 | MM1385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 4.69e-04 | 18 | 122 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.69e-04 | 18 | 122 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 4.69e-04 | 18 | 122 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 4.69e-04 | 18 | 122 | 3 | M3430 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 5.54e-04 | 19 | 122 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 5.54e-04 | 19 | 122 | 3 | M47543 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 5.55e-04 | 44 | 122 | 4 | M19784 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 6.47e-04 | 20 | 122 | 3 | MM1445 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 7.51e-04 | 21 | 122 | 3 | M11650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 7.51e-04 | 21 | 122 | 3 | M47542 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 8.64e-04 | 22 | 122 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 8.64e-04 | 22 | 122 | 3 | MM15519 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 9.87e-04 | 23 | 122 | 3 | MM15222 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 9.87e-04 | 23 | 122 | 3 | M47512 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.04e-03 | 133 | 122 | 6 | MM15529 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.12e-03 | 24 | 122 | 3 | M47509 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.27e-03 | 25 | 122 | 3 | M1547 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.27e-03 | 25 | 122 | 3 | MM15574 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 1.27e-03 | 25 | 122 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.27e-03 | 25 | 122 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.27e-03 | 25 | 122 | 3 | M47511 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 1.42e-03 | 26 | 122 | 3 | M17941 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.42e-03 | 26 | 122 | 3 | MM1371 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.52e-03 | 7 | 122 | 2 | M27947 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.57e-03 | 144 | 122 | 6 | MM14501 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.58e-03 | 58 | 122 | 4 | MM14914 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.77e-03 | 28 | 122 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 1.77e-03 | 28 | 122 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.77e-03 | 28 | 122 | 3 | M47508 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 1.77e-03 | 28 | 122 | 3 | M11362 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.96e-03 | 29 | 122 | 3 | MM15219 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 1.96e-03 | 29 | 122 | 3 | MM1495 | |
| Pathway | BIOCARTA_MALATEX_PATHWAY | 2.01e-03 | 8 | 122 | 2 | M22038 | |
| Pathway | BIOCARTA_MALATEX_PATHWAY | 2.01e-03 | 8 | 122 | 2 | MM1558 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 2.01e-03 | 8 | 122 | 2 | M10546 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.16e-03 | 30 | 122 | 3 | MM15170 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 2.16e-03 | 30 | 122 | 3 | M9664 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 2.38e-03 | 31 | 122 | 3 | MM14896 | |
| Pathway | KEGG_GLIOMA | 2.41e-03 | 65 | 122 | 4 | M1835 | |
| Pubmed | The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. | 2.21e-09 | 26 | 165 | 6 | 23077317 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HSPG2 MAN2A1 CALM1 COPB1 CALM2 GAPDH CALM3 USP9X PHB2 HKDC1 PSMD1 MCM5 VARS2 SIK3 ITGAV F13A1 TMX2 YIF1A FASN TMTC3 TLR3 ALAS1 HADHA MTCH2 BAG6 SEC23B | 5.69e-09 | 1451 | 165 | 26 | 30550785 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1B2 MIA3 CLTCL1 CALM1 COPB1 USP9X DNAH2 PHB2 EXOSC1 HKDC1 MCM5 SUCLG2 ARPC3 POLR3A G3BP2 RABGAP1L GET3 ANKRD17 BAG6 | 2.46e-08 | 847 | 165 | 19 | 35235311 |
| Pubmed | 7.10e-08 | 23 | 165 | 5 | 16799092 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 29932249 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.05e-07 | 3 | 165 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.05e-07 | 3 | 165 | 3 | 9923700 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.05e-07 | 3 | 165 | 3 | 23893133 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 1.05e-07 | 3 | 165 | 3 | 26170455 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.05e-07 | 3 | 165 | 3 | 8573130 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.05e-07 | 3 | 165 | 3 | 9278050 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.05e-07 | 3 | 165 | 3 | 11847276 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 10416864 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 7828884 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 8862395 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.05e-07 | 3 | 165 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.05e-07 | 3 | 165 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.05e-07 | 3 | 165 | 3 | 8631777 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 18553937 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.05e-07 | 3 | 165 | 3 | 11054265 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 33191766 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 18940602 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 25268113 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 19651602 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 26969752 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.05e-07 | 3 | 165 | 3 | 11807546 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 8312049 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 37380439 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.05e-07 | 3 | 165 | 3 | 11710561 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.05e-07 | 3 | 165 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.05e-07 | 3 | 165 | 3 | 3384819 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.05e-07 | 3 | 165 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.05e-07 | 3 | 165 | 3 | 18786401 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 11072229 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 1.05e-07 | 3 | 165 | 3 | 33603190 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 16229872 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 15063758 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 8226798 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.05e-07 | 3 | 165 | 3 | 17582331 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | GAPDH VARS2 RIF1 FASN SLC25A1 GET3 PRMT1 SLC25A11 HADHA BAG6 | 1.16e-07 | 221 | 165 | 10 | 29991511 |
| Pubmed | HSPG2 ATP6V1B2 COPB1 GAPDH PHB2 MCM5 ITGAV ARPC3 PDLIM5 FASN AP2A2 SLC25A1 PRMT1 HADHA BAG6 SEC23B | 2.96e-07 | 707 | 165 | 16 | 19738201 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MIA3 CLTCL1 SELENBP1 COPB1 GAPDH PHB2 AP1M2 PSMD1 ARPC3 FASN AP2A2 SLC25A1 PRMT1 SLC25A11 HADHA MTCH2 HYDIN | 3.38e-07 | 807 | 165 | 17 | 30575818 |
| Pubmed | PNKP CLTCL1 COPB1 PHB2 EXOSC1 XPO4 PSMD1 MCM5 YTHDC2 HMGCR SUCLG2 ARPC3 POLR3A FASN PXDN AP2A2 POMP G3BP2 ASCC2 PRMT1 SLC25A11 HADHA BAG6 | 3.64e-07 | 1440 | 165 | 23 | 30833792 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPHX2 HSPG2 ATP6V1B2 GIPC2 MAN2A1 SELENBP1 GAPDH CC2D1A GRID1 CNKSR2 ITGAV ARPC3 SLC4A1 ACE2 FASN SLC46A3 SLC22A13 SLC25A1 GET3 | 4.06e-07 | 1016 | 165 | 19 | 19056867 |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 4.18e-07 | 4 | 165 | 3 | 7607248 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 27516456 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 16709836 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 4.18e-07 | 4 | 165 | 3 | 23040497 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 16299511 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 25437912 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 4.18e-07 | 4 | 165 | 3 | 15499021 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 10692436 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 16478480 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 4.18e-07 | 4 | 165 | 3 | 16127172 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 20226167 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 4.18e-07 | 4 | 165 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 4.18e-07 | 4 | 165 | 3 | 14960328 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 22405011 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 4.18e-07 | 4 | 165 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 4.18e-07 | 4 | 165 | 3 | 11807557 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 11286509 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 20953164 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 4.18e-07 | 4 | 165 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 4.18e-07 | 4 | 165 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 4.18e-07 | 4 | 165 | 3 | 8780394 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 19279214 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 4.18e-07 | 4 | 165 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 4.18e-07 | 4 | 165 | 3 | 20103772 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 9096366 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 12577052 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 4.18e-07 | 4 | 165 | 3 | 22067155 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 25441029 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 16505387 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 26164367 | ||
| Pubmed | KCTD9 CALM1 CALM2 CALM3 USP9X DNAH2 SIK3 POLR3A NEK1 ATP2C1 AP2A2 RPS6KA6 PRMT1 PLA2G4F HCK SEC23B | 4.53e-07 | 730 | 165 | 16 | 34857952 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | COPB1 USP9X PHB2 PSMD1 MCM5 FASN SLC25A1 PRMT1 SLC25A11 HADHA | 4.83e-07 | 258 | 165 | 10 | 21081666 |
| Pubmed | ATP6V1B2 PNKP SELENBP1 CALM1 COPB1 GAPDH SHC1 PSMD1 MCM5 PDLIM5 FASN AP2A2 SLC25A1 G3BP2 GET3 ASCC2 PKP2 ANKRD17 SLC25A11 HADHA MTCH2 | 5.29e-07 | 1247 | 165 | 21 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CALM1 COPB1 CALM2 GAPDH CALM3 USP9X PHB2 PSMD1 MCM5 HMGCR ARPC3 POLR3A RIF1 FASN SLC25A1 G3BP2 PRMT1 SLC25A11 HADHA BAG6 SEC23B | 6.01e-07 | 1257 | 165 | 21 | 37317656 |
| Pubmed | HSPG2 CALM1 CALM2 GAPDH PRSS16 USP9X PHB2 MUC16 MCM5 FASN AP2A2 SLC25A1 PRMT1 SLC25A11 HADHA MTCH2 SEC23B | 6.27e-07 | 844 | 165 | 17 | 25963833 | |
| Pubmed | KCTD9 MIA3 CALM1 CALM2 NUMBL USP28 USP9X PHB2 CNKSR2 SIK3 HCN2 ARPC3 FRY AP2A2 G3BP2 ANKRD17 PRMT1 BSN | 8.43e-07 | 963 | 165 | 18 | 28671696 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 27165696 | ||
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 11981030 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 1.04e-06 | 5 | 165 | 3 | 11741295 | |
| Interaction | IQCG interactions | 7.94e-07 | 10 | 161 | 4 | int:IQCG | |
| Interaction | INSIG2 interactions | 1.29e-05 | 177 | 161 | 9 | int:INSIG2 | |
| Interaction | FN1 interactions | HSPG2 ATP6V1B2 COPB1 GAPDH PHB2 MCM5 ITGAV ARPC3 F13A1 PDLIM5 CER1 ACE2 FASN AP2A2 SLC25A1 PRMT1 HADHA ZKSCAN4 BAG6 SEC23B | 1.47e-05 | 848 | 161 | 20 | int:FN1 |
| Interaction | SPATA17 interactions | 1.71e-05 | 7 | 161 | 3 | int:SPATA17 | |
| Interaction | AGR2 interactions | NRIP1 MIA3 CLTCL1 SELENBP1 COPB1 GAPDH PHB2 AP1M2 PSMD1 ARPC3 FASN AP2A2 SLC25A1 GET3 PRMT1 SLC25A11 HADHA MUC5AC MTCH2 HCK HYDIN | 1.81e-05 | 934 | 161 | 21 | int:AGR2 |
| Interaction | PHKA2 interactions | 1.87e-05 | 69 | 161 | 6 | int:PHKA2 | |
| Interaction | HSP90AB1 interactions | KCTD9 ATP6V1B2 GIPC2 GAPDH DNAH2 SHC1 PSMD1 MCM5 CC2D1A SIK3 DOCK5 ACE2 FASN TTC23 SLC25A1 PRMT1 UNC13C HADHA MTCH2 HCK SEC23B | 2.71e-05 | 960 | 161 | 21 | int:HSP90AB1 |
| Interaction | KCNN1 interactions | 2.72e-05 | 8 | 161 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 2.72e-05 | 8 | 161 | 3 | int:ARPP21 | |
| Interaction | CFD interactions | HSPG2 MAN2A1 CALM1 COPB1 CALM2 GAPDH CALM3 USP9X PHB2 HKDC1 PSMD1 MCM5 VARS2 SIK3 ITGAV F13A1 TMX2 YIF1A FASN TMTC3 TLR3 ALAS1 HADHA MTCH2 BAG6 SEC23B | 2.88e-05 | 1360 | 161 | 26 | int:CFD |
| Interaction | CAMKK1 interactions | 3.97e-05 | 48 | 161 | 5 | int:CAMKK1 | |
| Interaction | FNDC5 interactions | HSPG2 MAN2A1 CALM1 COPB1 CALM2 GAPDH CALM3 USP9X PHB2 HKDC1 PSMD1 MCM5 VARS2 SIK3 ITGAV F13A1 TMX2 YIF1A FASN TMTC3 TLR3 ALAS1 HADHA MUC5AC MTCH2 BAG6 SEC23B | 3.97e-05 | 1470 | 161 | 27 | int:FNDC5 |
| Interaction | HDAC5 interactions | NRIP1 COPB1 USP9X PHB2 PSMD1 MCM5 SIK3 FRY FASN SLC25A1 PRMT1 SLC25A11 HADHA | 4.55e-05 | 432 | 161 | 13 | int:HDAC5 |
| Interaction | ZNF598 interactions | COPB1 GAPDH USP9X PHB2 PSMD1 PDLIM5 ACE2 FASN SLC25A1 ANKRD17 PRMT1 MTCH2 BAG6 | 4.89e-05 | 435 | 161 | 13 | int:ZNF598 |
| Interaction | EED interactions | HSPG2 PNKP MAN2A1 SELENBP1 CALM1 COPB1 CENPC GAPDH USP9X PHB2 XPO4 PSMD1 MCM5 ARPC3 TMX2 RIF1 FASN PXDN AP2A2 GET3 PKP2 SLC25A11 HADHA MTCH2 BAG6 SEC23B | 7.92e-05 | 1445 | 161 | 26 | int:EED |
| Interaction | FEZ1 interactions | 8.48e-05 | 90 | 161 | 6 | int:FEZ1 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 1.16e-05 | 23 | 163 | 4 | MM694 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 1.63e-05 | 51 | 163 | 5 | MM647 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | HSPG2 ATP6V1B2 ABCC4 MAN2A1 CALM1 NELFA USP9X PHB2 SH3GLB2 PSMD1 HMGCR ARPC3 PDLIM5 MEST FASN ATP2C1 G3BP2 GET3 PRMT1 SLC25A11 ALAS1 HADHA MTCH2 | 1.95e-05 | 1399 | 163 | 23 | M535 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-09 | 184 | 165 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-09 | 184 | 165 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-09 | 184 | 165 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 5.46e-07 | 189 | 165 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.92e-07 | 195 | 165 | 8 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 165 | 165 | 7 | 95866f7cc6eb1bb51a034a104a0eb2a53b0256f2 | |
| ToppCell | Club-club-12|World / Class top | 2.81e-06 | 165 | 165 | 7 | 9b7a31cbdcd2f96b8bd08a4cd4141b92bd5e9062 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 165 | 165 | 7 | f8bfe336b9a4460b9349c01acd0bd3167812662f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Deptor_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.12e-06 | 108 | 165 | 6 | 514dfc3f7ac303311ae599f981f3f3c7eb6801b8 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-06 | 169 | 165 | 7 | 08ac28c5ad8f5c5f9f54af341bf39e8f9417636e | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-06 | 169 | 165 | 7 | e5abd41db1e6724ad900e37658fa063b8e522908 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-06 | 171 | 165 | 7 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 176 | 165 | 7 | ce950805aaa3d39630376028ecd7da584fdb4394 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 176 | 165 | 7 | 5b65693833e02c08530488cbe37883e7c75f312e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-06 | 178 | 165 | 7 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-06 | 182 | 165 | 7 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.75e-06 | 184 | 165 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 6.23e-06 | 70 | 165 | 5 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(4)_1wkpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 6.32e-06 | 122 | 165 | 6 | b2a070939c0660c82a1130ef423fd627e9e087ab | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-06 | 187 | 165 | 7 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.40e-06 | 187 | 165 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Epithelial-Epithelial-D_(Clara-Club_cells)|Epithelial / shred on cell class and cell subclass (v4) | 6.62e-06 | 123 | 165 | 6 | caa1576f1b5eb592d522be61c090ac444e277ac5 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.10e-06 | 190 | 165 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.13e-06 | 194 | 165 | 7 | 784b15119c91ace33d34bfb3d68c182566a3e9a8 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 8.13e-06 | 194 | 165 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 152 | 165 | 6 | 9391b46a441cf031665df1d142e3f65e98675eeb | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 156 | 165 | 6 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 156 | 165 | 6 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 161 | 165 | 6 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | COVID-19_Severe-PLT_3|COVID-19_Severe / Disease Group and Platelet Clusters | 3.06e-05 | 161 | 165 | 6 | cd4ed3fa3cd8b159ab10cf9b2ad5cd05640530d0 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.28e-05 | 163 | 165 | 6 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.39e-05 | 164 | 165 | 6 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 165 | 165 | 6 | 6fdce8b23736409a23884ef3918638ffc067a86f | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 165 | 165 | 6 | dd4d36ff8efb89fee1fb4c48d1b8f46902119909 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 165 | 165 | 6 | baff639a7046fb5cacb70f341b6d24cef3519f8e | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-05 | 173 | 165 | 6 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 5.03e-05 | 176 | 165 | 6 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.19e-05 | 177 | 165 | 6 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-05 | 177 | 165 | 6 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.52e-05 | 179 | 165 | 6 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-05 | 181 | 165 | 6 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 181 | 165 | 6 | a52e367f0909689174b3534f0cd51f36abe1b49f | |
| ToppCell | tumor_Lung-Myeloid_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 6.24e-05 | 183 | 165 | 6 | 7ef79365514e62dfc2e182e873e2b413d4f46b46 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.24e-05 | 183 | 165 | 6 | 514b72a1ae55656934839800513385e19bc240e2 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.44e-05 | 184 | 165 | 6 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.44e-05 | 184 | 165 | 6 | 41164109d9d7bb1c431220e2e85e08dc5f56856d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.44e-05 | 184 | 165 | 6 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.44e-05 | 184 | 165 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.63e-05 | 185 | 165 | 6 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 185 | 165 | 6 | 9ef66bf63ed728cbf3044520a2a1625a9d5863a4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 185 | 165 | 6 | 2148b78db2afaf29b01d604d314d6061179e2663 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.63e-05 | 185 | 165 | 6 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 186 | 165 | 6 | 6c06163d7315f1c71b15fe76f2e696bf3fa73b67 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 186 | 165 | 6 | 78e3b00eb347d1aa197671e31be9b0c6e4235760 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.04e-05 | 187 | 165 | 6 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-05 | 188 | 165 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.91e-05 | 191 | 165 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 191 | 165 | 6 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 191 | 165 | 6 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.37e-05 | 193 | 165 | 6 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.37e-05 | 193 | 165 | 6 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.37e-05 | 193 | 165 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.37e-05 | 193 | 165 | 6 | 47249aabdd912052aa635d276eed20d32b525393 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.37e-05 | 193 | 165 | 6 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.81e-05 | 121 | 165 | 5 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 9.11e-05 | 196 | 165 | 6 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.37e-05 | 197 | 165 | 6 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 9.37e-05 | 197 | 165 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 9.37e-05 | 197 | 165 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.64e-05 | 198 | 165 | 6 | 39e52fcd467b8041da977cfe25764df02a87990a | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Monocytes,_Macrophages|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.64e-05 | 198 | 165 | 6 | b32ca1b5d88b13a39f2cd4e129ea031f97475d29 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.64e-05 | 198 | 165 | 6 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.64e-05 | 198 | 165 | 6 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.64e-05 | 198 | 165 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Severe-CD4+_T_Exhausted|World / Disease group and Cell class | 9.91e-05 | 199 | 165 | 6 | 467c34893dd7d1a8a1c101c966f034cc04b9bcbd | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 9.91e-05 | 199 | 165 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Severe-CD4+_T_Exhausted|Severe / Disease group and Cell class | 9.91e-05 | 199 | 165 | 6 | dc6b0291714e2b9501c0796a63678bfb9d1b1052 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-05 | 199 | 165 | 6 | 3d8c76e3d05acf72a35ca755b51579fc3ae63562 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-04 | 200 | 165 | 6 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | 70c2e577efb6b6fe8f9d970d7ecc470788efb85b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.32e-04 | 70 | 165 | 4 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.47e-04 | 135 | 165 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| Drug | DyCl3 | 8.50e-08 | 7 | 162 | 4 | CID000066207 | |
| Drug | NSC366363 | 3.54e-07 | 3 | 162 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 3.54e-07 | 3 | 162 | 3 | CID004630710 | |
| Drug | tatsiensine | 3.54e-07 | 3 | 162 | 3 | CID000163526 | |
| Drug | delcosine | 3.54e-07 | 3 | 162 | 3 | CID000120726 | |
| Drug | NSC381866 | HSPG2 ATP6V1B2 CLTCL1 MAN2A1 CALM1 COPB1 CALM2 CALM3 ATP2C1 TLR3 | 3.81e-07 | 169 | 162 | 10 | CID000002287 |
| Drug | AC1Q5XN5 | 7.84e-07 | 11 | 162 | 4 | CID000190946 | |
| Drug | Nsc642900 | 1.41e-06 | 4 | 162 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 1.41e-06 | 4 | 162 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 1.41e-06 | 4 | 162 | 3 | CID006439702 | |
| Drug | cloxacepride | 1.41e-06 | 4 | 162 | 3 | CID000068859 | |
| Drug | chloraniformethan | 1.41e-06 | 4 | 162 | 3 | CID000030331 | |
| Drug | Ti 233 | 1.41e-06 | 4 | 162 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 1.41e-06 | 4 | 162 | 3 | CID000080867 | |
| Drug | herbarumin III | 1.41e-06 | 4 | 162 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 1.41e-06 | 4 | 162 | 3 | CID000070583 | |
| Drug | KS-504e | 1.41e-06 | 4 | 162 | 3 | CID000129559 | |
| Drug | KS-504d | 1.41e-06 | 4 | 162 | 3 | CID000129557 | |
| Drug | Archanagelicine | 1.41e-06 | 4 | 162 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 1.41e-06 | 4 | 162 | 3 | CID000127194 | |
| Drug | Roylin | 1.41e-06 | 4 | 162 | 3 | CID000099924 | |
| Drug | KS-502 | 1.41e-06 | 4 | 162 | 3 | CID000129242 | |
| Drug | KS-501 | 1.41e-06 | 4 | 162 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 1.41e-06 | 4 | 162 | 3 | CID000637889 | |
| Drug | PS-990 | 1.41e-06 | 4 | 162 | 3 | CID000157810 | |
| Drug | PD140548 | 1.68e-06 | 13 | 162 | 4 | CID005311347 | |
| Drug | SC-52458 | 1.68e-06 | 13 | 162 | 4 | CID000132706 | |
| Drug | A71623 | 1.68e-06 | 13 | 162 | 4 | CID000121964 | |
| Drug | jujubogenin | 3.50e-06 | 5 | 162 | 3 | CID005318721 | |
| Drug | D 890 | 3.50e-06 | 5 | 162 | 3 | CID000134083 | |
| Drug | NSC-36360 | 3.50e-06 | 5 | 162 | 3 | CID000133340 | |
| Drug | alpha-CAO | 3.50e-06 | 5 | 162 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 3.50e-06 | 5 | 162 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 3.50e-06 | 5 | 162 | 3 | CID000021396 | |
| Drug | Y-acid | 3.50e-06 | 5 | 162 | 3 | CID000007022 | |
| Drug | C16AA | 3.50e-06 | 5 | 162 | 3 | CID000488017 | |
| Drug | auranthine | 3.50e-06 | 5 | 162 | 3 | CID000130919 | |
| Drug | Ant-ATP | 3.50e-06 | 5 | 162 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 3.50e-06 | 5 | 162 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 3.50e-06 | 5 | 162 | 3 | CID005748474 | |
| Drug | Ac-dvda | 3.50e-06 | 5 | 162 | 3 | CID000146768 | |
| Drug | VUF 4576 | 3.50e-06 | 5 | 162 | 3 | CID000132784 | |
| Drug | deuteroheme | 4.04e-06 | 34 | 162 | 5 | CID000167768 | |
| Drug | SR 27897 | 5.47e-06 | 17 | 162 | 4 | CID000122077 | |
| Drug | CDP-I | 5.47e-06 | 17 | 162 | 4 | CID000180517 | |
| Drug | AC1NSV6X | 6.96e-06 | 6 | 162 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 6.96e-06 | 6 | 162 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 6.96e-06 | 6 | 162 | 3 | CID000020218 | |
| Drug | benziodarone | 6.96e-06 | 6 | 162 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 6.96e-06 | 6 | 162 | 3 | CID000633347 | |
| Drug | CI-922 | 6.96e-06 | 6 | 162 | 3 | CID000146938 | |
| Drug | caged PE | 6.96e-06 | 6 | 162 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 6.96e-06 | 6 | 162 | 3 | CID000145934 | |
| Drug | 1H-imidazole hydrochloride | 6.99e-06 | 18 | 162 | 4 | CID000518985 | |
| Drug | dibromobimane | 8.81e-06 | 19 | 162 | 4 | CID000125708 | |
| Drug | 1-(4-pyridyl)ethanol | 1.21e-05 | 7 | 162 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 1.21e-05 | 7 | 162 | 3 | CID000196983 | |
| Drug | chloronitromethane | 1.21e-05 | 7 | 162 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 1.21e-05 | 7 | 162 | 3 | CID000159622 | |
| Drug | DAPpNP | 1.21e-05 | 7 | 162 | 3 | CID005492375 | |
| Drug | T 7188 | 1.21e-05 | 7 | 162 | 3 | CID000003311 | |
| Drug | MS-857 | 1.21e-05 | 7 | 162 | 3 | CID000129517 | |
| Drug | SQ 65442 | 1.21e-05 | 7 | 162 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 1.21e-05 | 7 | 162 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 1.21e-05 | 7 | 162 | 3 | CID000188375 | |
| Drug | TZC-5665 | 1.21e-05 | 7 | 162 | 3 | CID006449836 | |
| Drug | KHL-8430 | 1.21e-05 | 7 | 162 | 3 | CID000195711 | |
| Drug | CPU57 | 1.21e-05 | 7 | 162 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 1.21e-05 | 7 | 162 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 1.21e-05 | 7 | 162 | 3 | CID003081980 | |
| Drug | asocainol | 1.21e-05 | 7 | 162 | 3 | CID000071161 | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; PC3; HT_HG-U133A | 1.33e-05 | 199 | 162 | 9 | 5772_UP | |
| Drug | P12-14 | 1.34e-05 | 21 | 162 | 4 | CID000626783 | |
| Drug | 26 C | 1.34e-05 | 21 | 162 | 4 | CID005327159 | |
| Drug | orthovanadate | ATP6V1B2 ABCC4 CALM1 COPB1 CALM2 CALM3 SHC1 ARPC3 SLC4A1 PIGQ ATP2C1 ART3 GET3 | 1.49e-05 | 435 | 162 | 13 | CID000061672 |
| Drug | proxyl nitroxide | 1.93e-05 | 8 | 162 | 3 | CID000076702 | |
| Drug | niludipine | 1.93e-05 | 8 | 162 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 1.93e-05 | 8 | 162 | 3 | CID000065839 | |
| Drug | HT-74 | 1.93e-05 | 8 | 162 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 1.93e-05 | 8 | 162 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 1.93e-05 | 8 | 162 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 1.93e-05 | 8 | 162 | 3 | CID000467415 | |
| Drug | KS-504a | 1.93e-05 | 8 | 162 | 3 | CID000129577 | |
| Drug | NSP-805 | 1.93e-05 | 8 | 162 | 3 | CID000130349 | |
| Drug | R7 1 | 1.93e-05 | 8 | 162 | 3 | CID000001949 | |
| Drug | AC1L25Y6 | 1.97e-05 | 23 | 162 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 1.97e-05 | 23 | 162 | 4 | CID000165791 | |
| Drug | cyhexatin | 2.78e-05 | 25 | 162 | 4 | CID005364545 | |
| Drug | w66 | 2.88e-05 | 9 | 162 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 2.88e-05 | 9 | 162 | 3 | CID000159916 | |
| Drug | adamantanone | 2.88e-05 | 9 | 162 | 3 | CID000064151 | |
| Drug | picumast | 2.88e-05 | 9 | 162 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 2.88e-05 | 9 | 162 | 3 | CID000440017 | |
| Drug | KS-505a | 2.88e-05 | 9 | 162 | 3 | CID003081782 | |
| Drug | Nchembio861-comp5 | 3.40e-05 | 52 | 162 | 5 | CID004476950 | |
| Drug | AC1L1G7Z | 3.81e-05 | 27 | 162 | 4 | CID000003567 | |
| Drug | Ci988 | 3.81e-05 | 27 | 162 | 4 | CID000108186 | |
| Drug | idoxifene | 3.81e-05 | 27 | 162 | 4 | CID003034011 | |
| Drug | Kr I | 4.09e-05 | 10 | 162 | 3 | CID005288675 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 4.09e-05 | 10 | 162 | 3 | CID000152034 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.86e-05 | 10 | 161 | 3 | C1631597 | |
| Disease | keratoconjunctivitis (is_marker_for) | 8.84e-05 | 3 | 161 | 2 | DOID:9368 (is_marker_for) | |
| Disease | myofibrillar myopathy 4 (implicated_via_orthology) | 8.84e-05 | 3 | 161 | 2 | DOID:0080095 (implicated_via_orthology) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 1.97e-04 | 21 | 161 | 3 | DOID:10808 (biomarker_via_orthology) | |
| Disease | hereditary spherocytosis (is_implicated_in) | 2.93e-04 | 5 | 161 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 2.93e-04 | 5 | 161 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 2.93e-04 | 5 | 161 | 2 | C0221409 | |
| Disease | Phencyclidine-Related Disorders | 6.10e-04 | 7 | 161 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 6.10e-04 | 7 | 161 | 2 | C0031391 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 6.10e-04 | 7 | 161 | 2 | C2745997 | |
| Disease | Hereditary spherocytosis | 8.11e-04 | 8 | 161 | 2 | C0037889 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 8.11e-04 | 8 | 161 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | Cocaine Dependence | 1.02e-03 | 139 | 161 | 5 | C0600427 | |
| Disease | Cannabis Abuse | 1.29e-03 | 10 | 161 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.29e-03 | 10 | 161 | 2 | C0236735 | |
| Disease | Hashish Abuse | 1.29e-03 | 10 | 161 | 2 | C0018614 | |
| Disease | dry eye syndrome (is_marker_for) | 1.29e-03 | 10 | 161 | 2 | DOID:10140 (is_marker_for) | |
| Disease | reticulocyte count | GIPC2 ANK1 COPB1 USP9X WNT6 DENND2B SLC4A1 PIGQ TMX2 DOCK5 RIMKLB PTPRH ASCC2 BSN | 1.82e-03 | 1045 | 161 | 14 | EFO_0007986 |
| Disease | hyperglycemia (is_marker_for) | 2.22e-03 | 13 | 161 | 2 | DOID:4195 (is_marker_for) | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 2.22e-03 | 13 | 161 | 2 | OBA_2045174 | |
| Disease | myopathy (implicated_via_orthology) | 2.30e-03 | 48 | 161 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 2.44e-03 | 49 | 161 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Left ventricular noncompaction | 2.58e-03 | 14 | 161 | 2 | C1960469 | |
| Disease | endometriosis | 2.68e-03 | 252 | 161 | 6 | EFO_0001065 | |
| Disease | S-7-hydroxywarfarin measurement | 3.15e-03 | 110 | 161 | 4 | EFO_0803329 | |
| Disease | Hyperlipoproteinemia Type IIa | 3.38e-03 | 16 | 161 | 2 | C0745103 | |
| Disease | Romano-Ward Syndrome | 3.38e-03 | 16 | 161 | 2 | C0035828 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.38e-03 | 16 | 161 | 2 | C0393706 | |
| Disease | Schizophrenia | EPHX2 NRIP1 RELN SELENBP1 NUMBL PRSS16 GRID1 CLOCK PDLIM5 TLR3 ZKSCAN4 RIMS2 | 3.42e-03 | 883 | 161 | 12 | C0036341 |
| Disease | hematocrit | ZYG11A NRIP1 STK36 NUMBL DNAH2 HKDC1 DENND2B SLC4A1 POMP RABGAP1L ANKRD17 BSN HYDIN | 3.74e-03 | 1011 | 161 | 13 | EFO_0004348 |
| Disease | Cannabis Dependence | 3.81e-03 | 17 | 161 | 2 | C0006870 | |
| Disease | Polydactyly | 3.93e-03 | 117 | 161 | 4 | C0152427 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.55e-03 | 61 | 161 | 3 | DOID:3587 (is_marker_for) | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.76e-03 | 19 | 161 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | GIPC2 ANK1 COPB1 CALM3 USP9X DENND2B SLC4A1 PIGQ DOCK5 RIMKLB PTPRH ASCC2 BSN | 5.24e-03 | 1053 | 161 | 13 | EFO_0010700 |
| Disease | glaucoma (is_marker_for) | 5.27e-03 | 20 | 161 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Familial aplasia of the vermis | 5.27e-03 | 20 | 161 | 2 | cv:C0431399 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 5.44e-03 | 65 | 161 | 3 | DOID:0080208 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGRAKESLGMLLQPD | 186 | Q68DN1 | |
| GPESNSGERLKAMLL | 176 | O75366 | |
| KVFLSGMPELRLGLN | 201 | Q9Y6Q5 | |
| KELGTVMRSLGQNPT | 31 | P0DP25 | |
| ITFGGLLGEKTRNQM | 421 | P02730 | |
| RKTMQGEGPQLLLSE | 1051 | P46379 | |
| NMLEGSGRQSRNLKP | 1481 | P16157 | |
| GNSPLLQKMIGNIFT | 171 | Q9H1I8 | |
| QSLRGAMLEPFGVNS | 4231 | Q6V0I7 | |
| KQAVSLLGPDGINTM | 586 | A6QL63 | |
| LNTPKIDMERLLGGQ | 86 | Q8TF65 | |
| RGIKGDITPLMAAAN | 296 | O75179 | |
| TSPAGEGQRQREKML | 66 | O95813 | |
| MELLKLNRSVQGTGP | 1 | P32239 | |
| LPDTEQSGMNKFLRG | 1111 | P78524 | |
| KELGTVMRSLGQNPT | 31 | P0DP24 | |
| MANEVQDLLSPRKGG | 1 | A0PJW8 | |
| IRNNTLMGKPTEGAL | 416 | P98194 | |
| IFGTIGMRPNAKNNR | 331 | Q99873 | |
| IKNDLASRNPTFMGL | 116 | O94973 | |
| IFAGPDTKLMQNSGR | 266 | P98198 | |
| KGQETSMSPGRREQL | 276 | Q2M243 | |
| PDGAGTMNKLRQSLR | 36 | Q9Y6R0 | |
| GNMSRGNSLFFRKVP | 276 | Q9Y6C9 | |
| NGKLPTRAMDFNGIL | 1811 | P98160 | |
| GITLKMPQQARGAES | 656 | Q4ADV7 | |
| PQGNKADDSRMSLLG | 101 | Q96N11 | |
| LLGAVQGFSRPQLMT | 866 | Q7RTW8 | |
| LQTLLGPMFKNTSVG | 12576 | Q8WXI7 | |
| NTTERVLQGLLGPMF | 12881 | Q8WXI7 | |
| VLQGLLGPMFKNTSV | 12886 | Q8WXI7 | |
| MRRVTLFLNGSPKNG | 1 | Q7L273 | |
| GPNLLEGLSKMRQEN | 56 | Q9H511 | |
| RLQGGKDFNMPLTIS | 16 | O75112 | |
| STGLFDANNPKMLRT | 1036 | Q96PY6 | |
| GSFPQGQLSMLQEKI | 41 | Q16706 | |
| KALILGFMAGSRENP | 456 | Q9H3P2 | |
| NLLMLGDPGTAKSQL | 376 | P33992 | |
| KAPVQQGSMRSLGLA | 1076 | Q6PRD1 | |
| GDPSGLLKNFQDIMQ | 161 | P13196 | |
| NIARGMAILGPTFTL | 156 | P04035 | |
| ERSMSAPGNLLVKEG | 471 | Q8N5S9 | |
| LFNAIPASLGMKLRG | 221 | Q9BYJ1 | |
| KVGSSMRPLLQAQGL | 726 | Q9UPA5 | |
| VGLNAPSMLRKNQLG | 21 | Q8NA75 | |
| MQALALGPGLKSQAE | 241 | A6NNH2 | |
| ILRNLKDHGPQMGTF | 996 | Q6ZWH5 | |
| RTGMNDLNAKLPGNI | 376 | Q86W56 | |
| NGEKLPGLLMTIIRF | 51 | P53618 | |
| TGNTDKPIGMIDRLN | 656 | P48552 | |
| AQMDLSGRGNPIKVS | 246 | P00488 | |
| GSMPLKNSFRGTIRK | 91 | Q9Y3B2 | |
| MLTGTLPFQGKDRNE | 266 | Q9UK32 | |
| MLFKRNPANRLGSEG | 306 | Q9UK32 | |
| DLSGMVLKQLVRGFP | 386 | Q8IXW0 | |
| FMQLAPKLRGQTCGL | 556 | P98088 | |
| FRLQGGKDFNMPLTI | 16 | Q96HC4 | |
| TAGGFQQLLLEPMLK | 311 | O75469 | |
| GSELFMGRLLQLQPE | 536 | Q68DD2 | |
| MAQNLKDLAGRLPAG | 1 | Q99623 | |
| FLNTLNQDTGMRKPA | 1146 | Q8IVE3 | |
| PLDLVKNRMQLSGEG | 41 | Q02978 | |
| FGMLLSPGRNVKNSD | 331 | Q5R372 | |
| QLESDRFLLMSGGKP | 2176 | P78509 | |
| MNARGLGSELKDSIP | 1 | Q9Y244 | |
| GMLRDVPQFLSGQLS | 796 | Q9UQ26 | |
| LFTGTMRKNLDPFNE | 1126 | O15439 | |
| GFGRTALQVMKLGNP | 36 | P42773 | |
| PQLTGLRMKGFLAQT | 51 | K7EIQ3 | |
| RQLLAPGNMLGSFMI | 156 | P08631 | |
| MALNRKVLSGEPAGT | 2701 | Q4G0P3 | |
| IGANLKPARDLGMVT | 186 | P34913 | |
| TFGQRLLGMLPSENS | 376 | Q86Z20 | |
| FVKLMNPDGTTLQDG | 551 | Q9H7D0 | |
| MEGPLFLQSQRFGTK | 6 | Q99704 | |
| NEGMSGLFGLKQRSI | 1671 | Q9H799 | |
| IGNMALLPIRSQFKG | 16 | O15145 | |
| RKTNLMVNLGIPLGD | 806 | Q03188 | |
| GLLSNSGQPERKFMQ | 96 | Q9UN86 | |
| VSLGRAKRAFLPGMN | 136 | Q9GZV9 | |
| PMKAGTQLLAGLRFS | 716 | P06756 | |
| ELRNNGPSSFSKAML | 811 | P06756 | |
| PFRSLEAINGSGLQM | 176 | P09172 | |
| QAKGLEPMLEASRNG | 526 | Q6P1N0 | |
| GQKLFNMLRLGKSEP | 551 | Q9BYF1 | |
| LRENQLLPGFELMGS | 121 | P35475 | |
| MARIFNGRPAQKGTT | 446 | P48740 | |
| PELLTQMVSKGFLGR | 616 | P40939 | |
| GLGRLMQIKNQISPF | 186 | O43681 | |
| DSEKGLNGSLQERPM | 416 | Q9ULK0 | |
| QERPMGSRLQGLTLK | 426 | Q9ULK0 | |
| TQTILRMFDLNGDGK | 156 | P22676 | |
| KELGTVMRSLGQNPT | 31 | P0DP23 | |
| ELQNSSGRDGKPRAM | 2346 | Q5TBA9 | |
| IAGMSGKLPESENLQ | 6 | P49327 | |
| RQEPLLIGSTKSNMG | 316 | P49327 | |
| LNPMLNKSVARIGGR | 3451 | Q9P225 | |
| AELFPTILRQTGMGL | 441 | Q9Y226 | |
| LQPGVNKFSLRMFGS | 171 | Q9UL51 | |
| ALLFGMVALVTKPGQ | 401 | Q14CX5 | |
| DGGVLSPILTRLMNF | 196 | Q5EB52 | |
| FEKGNLLPNLTARDM | 186 | P56373 | |
| PKQREGMALTLGLAA | 321 | Q6ZUA9 | |
| MLGTQLTGQLPFSKV | 631 | Q5ST30 | |
| AIDGMNSIARGQKIP | 176 | P21281 | |
| GGLPLVLSMLTRNNF | 1121 | Q93008 | |
| DMGCRLLPGSQQKSV | 116 | Q8N8N0 | |
| QNLSRGMESFPGKVL | 526 | B4DYI2 | |
| KIQQESLGSAPLMGD | 571 | Q5JRA6 | |
| NKIFAIPLEIMQGTG | 556 | Q2TB90 | |
| VNLKEMFSNSTGRLP | 36 | Q3BBV2 | |
| LGETPQNLSRDMKSF | 671 | Q5VVP1 | |
| QLEELGFRSGAPMIK | 276 | Q5UIP0 | |
| IPELNGKLTGMAFRV | 221 | P04406 | |
| PAGLKMNRALDQVLG | 331 | Q9BRB3 | |
| LFLNGNDIEKLTPGM | 461 | O94933 | |
| NDIEKLTPGMFRGLQ | 466 | O94933 | |
| RFNLQMDISGLIPGL | 71 | Q7Z3Q1 | |
| AGTGNKEAINLLEPM | 661 | Q99460 | |
| GMKNIVSAFGIIPRN | 456 | Q96PZ0 | |
| VLMGTKANLVTPRNG | 521 | O14802 | |
| MLDLQKQLGRFPGTF | 271 | Q9NR46 | |
| VQLDNLPGMSLVAGK | 1226 | Q9Y2K2 | |
| KRVAGGPQMIQLSLD | 381 | Q13228 | |
| FTNQMSIGRGKLPAE | 216 | Q96T60 | |
| LLEGTFPNTGARIML | 276 | Q15437 | |
| FRLQNLPCGMEKLGS | 771 | Q9NRP7 | |
| MLTGISPFLGNDKQE | 256 | Q9UEE5 | |
| MLSGFPNRLQKELSS | 366 | Q9Y615 | |
| NVLIKELGSMLPGNA | 51 | O15516 | |
| FLLRGVMKISPEQGL | 516 | P53675 | |
| QAPMAGALNRKESFL | 36 | A5D8T8 | |
| QAPMAGALNRKESFL | 36 | Q6UXF7 | |
| QAPMAGALNRKESFL | 36 | Q8NCF0 | |
| RMQVLNGNGGKPRSF | 831 | Q8WXI2 | |
| QLPTLILFQGGKEAM | 216 | Q9Y320 | |
| RMAENLGFVGPLKSQ | 206 | Q96I99 | |
| DIPGIKSNMFTGLIN | 366 | O15455 | |
| LLAGMALGIQKRFSP | 151 | O95070 | |
| PVQRTLMKALVLGGF | 746 | Q9C0E2 | |
| FGKTLNLGMNSVPSR | 116 | Q9HCZ1 | |
| GPQMIFIAAKDLGQL | 1941 | Q8NB66 | |
| RLMFGDGTQLVVKPN | 121 | P0DTU3 | |
| RSQMTFGRLQGIFPK | 96 | Q7RTT3 | |
| VPQRGKTSELLDMFG | 596 | Q9H0I9 | |
| LFGVAGKMRVPSQLL | 1121 | Q92626 | |
| FGNTPLDVIKTRMQG | 236 | P53007 | |
| MGTNDGKALLPAVRT | 261 | Q9Y6F9 | |
| SMILGRQQPATEKRG | 2021 | Q68DE3 | |
| ELLTKLPGGLFNMNQ | 361 | Q9ULI2 | |
| QSNAALLMKGPRRGV | 926 | Q96RU2 | |
| DLGPQERMQISKFTG | 876 | Q9NRE2 | |
| PAGLLDLRQGMFAQL | 81 | P41273 | |
| LNMNFVPLRKSNSEG | 116 | P51523 | |
| KATGGPLKNMVLFTR | 186 | Q9P016 | |
| FNLNPNLILRGGMKF | 136 | Q6ZSS3 | |
| REMSKTSGRLNNGIP | 161 | Q9H6S0 | |
| SRLTPGSQGLLKMED | 211 | Q969J2 | |
| MRKNGSLQRPLQSGI | 516 | Q8TEC5 | |
| GPQDKRTLATQQAMG | 391 | Q5W5X9 | |
| NLKDMAPGLGSETRL | 486 | Q96S15 | |
| ERPKQNIITGNFLMG | 1306 | Q9BXT5 | |
| FLRGKGSIPFSMLQT | 221 | Q6ZXV5 | |
| QSEGLLGPFSFVRKM | 1041 | Q9HD43 | |
| ALNLTRQGLAKGMPV | 406 | Q6WRX3 | |
| FGTKGNLCQRKMPLS | 76 | Q9P0N5 | |
| LSIPAGGLEMAQLRF | 136 | Q9NQE7 | |
| QVNLGPSINSKLLGM | 61 | Q7Z4V0 | |
| PGTSRSMGNLLEKEN | 246 | Q99959 | |
| PSGQDLRATMQRKGI | 176 | P50607 | |
| GRSNLKFAGMPITLT | 221 | P29353 | |
| MPQGSLKLLGRSDQA | 626 | Q9H1B5 | |
| RKAMEGTIDGSLINP | 31 | Q9Y3C4 | |
| ASSGKLLLPQFGMVI | 361 | Q13508 |